Receptor Nature and Ligand Requirements
Unlike membrane targets, intracellular receptors are soluble proteins located directly inside the cell, either in the cytosol or the nucleus. This localization imposes strict requirements on the substances (agonists) capable of interacting with them.
To reach its target, the ligand must independently cross the plasma membrane. This is only possible for lipophilic substances. Classic examples of such compounds include:
- Steroid hormones (including glucocorticoids and sex hormones).
- Thyroid hormones.
- Fat-soluble vitamins (groups A/retinoids and D).
Genomic Effect: Activation Cascade
The mechanism of action of substances acting via nuclear receptors occurs at the genetic level and is a complex, multistep process. The entire sequence from molecular penetration to altered cellular function is called the genomic effect.
The process includes the following steps:
- The lipophilic ligand freely penetrates the cell.
- In the cytosol, the substance binds to its specific receptor.
- A conformational change occurs in the receptor structure.
- The resulting ligand-receptor complex translocates (moves) into the cell nucleus.
- Within the nucleus, the complex binds to specific DNA sequences.
This interaction alters gene transcription, which can be either activated or repressed (suppressed). In turn, this leads to an increase or decrease in the synthesis of functionally active proteins, such as enzymes or cytokines. Alteration of the cellular protein pool triggers a new biochemical cascade, manifesting as the drug's pharmacological effect.
Temporal Characteristics of the Response
A crucial pharmacological feature of drugs acting via intracellular receptors is the slow onset of effects.
Unlike ligand-gated ion channels, where the response occurs in milliseconds, there is a significant lag (latent) period ranging from several hours to a full day. This delay is due to the time required for the cell to execute the genetic program: initiating transcription, translation, and subsequent synthesis of sufficient quantities of new protein molecules.
Clinical Examples: Glucocorticoids and PPARs
The function of intracellular receptors is best understood using the classic model of glucocorticoids. These drugs produce two characteristic effects by altering gene expression:
- Metabolic effect (hyperglycemia). The hormone-receptor complex activates genes encoding gluconeogenesis enzymes, stimulating glucose synthesis and raising blood glucose levels.
- Anti-inflammatory and immunosuppressive effects. The drug represses (suppresses) genes encoding various pro-inflammatory agents, reducing the production of adhesion molecules, cytokines, and the enzyme cyclooxygenase.
Another important target in this group is PPARs (peroxisome proliferator-activated receptors). They play a key role in regulating lipid metabolism. In clinical practice, PPARs serve as the site of action for hypolipidemic drugs (e.g., clofibrate).